{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:24Z","timestamp":1786985424189,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["22NSFCP21"],"award-info":[{"award-number":["22NSFCP21"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260675"],"award-info":[{"award-number":["82260675"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["YB161"],"award-info":[{"award-number":["YB161"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["YB298"],"award-info":[{"award-number":["YB298"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["ZD031"],"award-info":[{"award-number":["ZD031"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["QKHZDZXZ[2024]015"],"award-info":[{"award-number":["QKHZDZXZ[2024]015"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017957","name":"Health Commission of Guizhou Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bmc.2025.118472","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:05:16Z","timestamp":1762207516000},"page":"118472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel trifluoromethylquinoline derivatives as potent tubulin polymerization inhibitors with antitumor activity"],"prefix":"10.1016","volume":"132","author":[{"given":"Mengsha","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangkai","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118472_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bmc.2025.118472_bb0010","unstructured":"From https:\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/prostate-advanced-patient.pdf, Prostate cancer: Advanced stage, Version 2022."},{"key":"10.1016\/j.bmc.2025.118472_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.746922","article-title":"Recent advances in medical therapy for urological cancers","volume":"12","author":"Yuasa","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2025.118472_bb0020","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","article-title":"Advanced prostate cancer: treatment advances and future directions","volume":"6","author":"Swami","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bmc.2025.118472_bb0025","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2025.118472_bb0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41580-018-0067-1","article-title":"Actin-microtubule crosstalk in cell biology","volume":"20","author":"Dogterom","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmc.2025.118472_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0955-0674(00)00173-3","article-title":"The tubulin fraternity: alpha to eta","volume":"13","author":"Dutcher","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.bmc.2025.118472_bb0040","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/13543776.2019.1648433","article-title":"Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018)","volume":"29","author":"Haider","year":"2019","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2025.118472_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","article-title":"Recent developments in tubulin polymerization inhibitors: an overview","volume":"87","author":"Kaur","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118472_bb0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2025.118472_bb0055","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1021\/acs.jmedchem.9b00551","article-title":"Structure guided design, synthesis, and biological evaluation of novel benzosuberene analogues as inhibitors of tubulin polymerization","volume":"62","author":"Niu","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118472_bb0060","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","article-title":"An overview of tubulin inhibitors that interact with the colchicine binding site","volume":"29","author":"Lu","year":"2012","journal-title":"Pharm Res"},{"key":"10.1016\/j.bmc.2025.118472_bb0065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1039\/c0ib00135j","article-title":"A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment","volume":"3","author":"Mason","year":"2011","journal-title":"Integr Biol"},{"key":"10.1016\/j.bmc.2025.118472_bb0070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ddr.20267","article-title":"Colchicine site inhibitors of microtubule integrity as vascular disrupting agents","volume":"69","author":"Lee","year":"2008","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmc.2025.118472_bb0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1535-7163.MCT-13-0791","article-title":"Targeting microtubules by natural agents for cancer therapy","volume":"13","author":"Mukhtar","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2025.118472_bb0080","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1021\/acs.jmedchem.7b01457","article-title":"Inhibit or evade multidrug resistance P-glycoprotein in cancer treatment","volume":"61","author":"Waghray","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118472_bb0085","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/13543776.2023.2291390","article-title":"Development of tubulin polymerization inhibitors as anticancer agents","volume":"33","author":"Peerzada","year":"2023","journal-title":"Expert Opin Ther Pat."},{"key":"10.1016\/j.bmc.2025.118472_bb0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and resistance to tubulin-binding agents","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2025.118472_bb0095","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1021\/bi00443a031","article-title":"Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin","volume":"28","author":"Lin","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2025.118472_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112110","article-title":"Developments of isocombretastatin A-4 derivatives as highly cytotoxic agents","volume":"190","author":"Hamze","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118472_bb0105","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/annonc\/mdq708","article-title":"Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer","volume":"22","author":"Zweifel","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bmc.2025.118472_bb0110","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/sj.bjc.6605650","article-title":"A phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer","volume":"102","author":"Rustin","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bmc.2025.118472_bb0115","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/acs.jmedchem.6b00158","article-title":"Design, synthesis, and evaluation of in vitro and in vivo anticancer activity of 4-substituted coumarins: a novel class of potent tubulin polymerization inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118472_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116869","article-title":"Discovery and biological evaluation of 6-aryl-4-(3,4,5-trimethoxyphenyl)quinoline derivatives with promising antitumor activities as novel colchicine-binding site inhibitors","volume":"279","author":"Xu","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118472_bb0125","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1158\/0008-5472.CAN-07-0127","article-title":"MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps","volume":"67","author":"Kasibhatla","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2025.118472_bb0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11060-014-1437-y","article-title":"A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC)","volume":"118","author":"Chamberlain","year":"2014","journal-title":"J Neuro-Oncol"},{"key":"10.1016\/j.bmc.2025.118472_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106727","article-title":"Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activity","volume":"139","author":"Liu","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118472_bb0140","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4155\/fmc-2023-0151","article-title":"Design, synthesis and bioevaluation of novel trifluoromethylquinoline derivatives as tubulin polymerization inhibitors","volume":"15","author":"Zhang","year":"2023","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2025.118472_bb0145","doi-asserted-by":"crossref","first-page":"9296","DOI":"10.3390\/ijms21239296","article-title":"Policing cancer: vitamin D arrests the cell cycle","volume":"21","author":"Bhoora","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"17","key":"10.1016\/j.bmc.2025.118472_bb0150","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.1021\/acs.jmedchem.1c01099","article-title":"Discovery of novel anti-breast-cancer inhibitors by synergistically antagonizing microtubule polymerization and aryl hydrocarbon receptor expression","volume":"64","author":"Wang","year":"2021","journal-title":"J Med Chem"},{"issue":"16","key":"10.1016\/j.bmc.2025.118472_bb0155","doi-asserted-by":"crossref","first-page":"17258","DOI":"10.1021\/acs.jmedchem.5c00785","article-title":"Novel diaryl-substituted pyrazolo[3,4-d]pyrimidines as tubulin\/CDC5L dual-targeting ligands: discovery, potent antitumor activity, and good metabolic stability","volume":"68","author":"Shi","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118472_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2019.01.026","article-title":"Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer","volume":"448","author":"Fu","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmc.2025.118472_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400182","article-title":"Synthesis and examination of 1,2,4-triazine-sulfonamide hybrids as potential inhibitory drugs: inhibition effects on AChE and GST enzymes in silico and in vitro conditions","volume":"357","author":"Rozbicki","year":"2024","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bmc.2025.118472_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140558","article-title":"Novel s-triazine derivatives as potential anticancer agents: synthesis, DFT, DNA binding, molecular docking, MD simulation and in silico ADMET profiling","volume":"1322","author":"Mushtaq","year":"2025","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2025.118472_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121162","article-title":"Dispersion-corrected DFT calculations and umbrella sampling simulations to investigate stability of chrysin-cyclodextrin inclusion complexes","volume":"319","author":"Kumar","year":"2023","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.bmc.2025.118472_bb0180","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/07391102.2013.770373","article-title":"Relationship between a point mutation S97C in CK1\u03b4 protein and its affect on ATP-binding affinity","volume":"32","author":"Kumar","year":"2014","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2025.118472_bb0185","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12539-009-0043-8","article-title":"Structural basis for the resilience of darunavir (TMC114) resistance major flap mutations of HIV-1 protease","volume":"1","author":"Purohit","year":"2009","journal-title":"Interdiscip Sci"},{"key":"10.1016\/j.bmc.2025.118472_bb0190","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s12013-014-0153-8","article-title":"Mutations in microRNA binding sites of CEP genes involved in cancer","volume":"70","author":"Gopalakrishnan","year":"2014","journal-title":"Cell Biochem Biophys"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:04:18Z","timestamp":1780635858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625004134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["S0968089625004134"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118472","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel trifluoromethylquinoline derivatives as potent tubulin polymerization inhibitors with antitumor activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118472"}}